Corp. (NASDAQ:BTMDW – Get Free Report)’s stock price dropped 16.3% during mid-day trading on Tuesday . The stock traded as ...

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone ...

Barclays PLC grew its stake in biote Corp. (NASDAQ:BTMD – Free Report) by 52.3% in the third quarter, Holdings Channel.com ...

Has biote Corp. (BTMD) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. biote Corp. is one of 1021 companies in the Medical group.

Fintel reports that on December 16, 2024, Craig-Hallum initiated coverage of biote (NasdaqGM:BTMD) with a Buy recommendation. Analyst Price Forecast Suggests 52.22% Upside As of December 3 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

One company value investors might notice is biote Corp. (BTMD). BTMD is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 12.10.

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.